2023 KTM Sponsorship Packet_3.7.23

More documents

Recommendations

Info

SURVIVOR SPOTLIGHT Blake Hastings Blake Hastings went into the clinic for an MRI of his foot for what he was sure was a broken bone. But sitting in the exam room alone, the then-37-year-old received the news he never expected to get: he had cancer. It was likely Ewing sarcoma, a type of cancer of the bones or the soft tissue around them. A family friend at his diagnosing clinic made a call that would change Blake’s life. Six hours later, Blake and Carey met with M Health Fairview orthopedic surgeon Denis Clohisy, M.D., a member of the renowned Masonic Cancer Center, University of Minnesota. “When it comes to Ewing sarcoma, it’s really premature to advise amputation until we’ve seen the effect of the chemotherapy,” Clohisy says. “In most cases, it shrinks the tumor and therefore results in a surgical treatment that’s less debilitating than one might have thought at the beginning.” Blake spent a grueling nine months in treatment – but at home. For weeks at a time, he’d barely leave his bed. He spent about 15 days in the hospital total. In the end, Blake was able to keep his leg, losing only part of his foot. About six weeks after his treatments had ended, he felt like he was back to “full steam.” And now, one month short of five years later, the Hastings couldn’t be happier about Blake’s recovery. “The U of M team really managed the care of the person and the health of the person,” Blake says. “I think the medical care is as important as providing that hope for someone, a family, that there is an end zone.” Today the Hastings family is back to life as usual – working, getting the kids to their activities, and going on vacations together. Blake likes to spend his time golfing, skiing, hunting, fishing, and playing basketball – and bragging that he can still beat his kids at any of these activities with only nine toes. 2023 KTM Sponsorship Packet_3.7.23.indd 6 3/7/2023 2:12:21 PM
OUR BENEFICIARIES Proceeds from the Killebrew-Thompson Memorial advance cancer research and care at St. Luke’s Cancer Institute and Masonic Cancer Center, University of Minnesota. KTM has donated $21.4 million to these institutions, which has gone directly to cancer research. Our beneficiaries leverage these funds four- to five-fold through matching grants and other funds, increasing the impact of our donation by up to $6 million annually. St. Luke’s Cancer Institute (SLCI) brings cuttingedge clinical trials to Idaho and the Northwest. SLCI provides access to experimental treatments usually only available at hospitals in larger metropolitan areas. Funds contributed by KTM cover research costs incurred by both enrolled patients and SLCI itself, making accessible new treatment pathways. The Masonic Cancer Center (MCC) is advancing cancer care beyond the chemotherapy and radiation treatments of the past. MCC is preeminent in the research of cell therapies to treat leukemia and solid tumor cancers. Support from KTM seeds high impact studies that contribute to the worldwide research community and that improve quality of life for patients and survivors. To learn more about the work of our beneficiaries, visit www.ktmgolf.com/cause 2023 KTM Sponsorship Packet_3.7.23.indd 7 3/7/2023 2:12:22 PM
Page 1 and 2: 2023 KTM Sponsorship Packet_3.7.23.
Page 5: ABOUT US The Killebrew-Thompson Mem
Page 9 and 10: GOLF COURSES Elkhorn Golf Course Fi
Page 11 and 12: Super Sponsors HELPING YOU SEE THE
Page 13 and 14: PARTICIPANT BENEFITS Participant re
Page 15 and 16: Beverage Cart Sponsor $5,000 • Si
Page 17 and 18: Horseback Riding Miners and rancher
Page 19 and 20: Awards Ceremony Saturday, August 19
Page 23 and 24: RESORT AMENITIES Spa at Sun Valley

2023 KTM Sponsorship Packet_3.7.23

Create successful ePaper yourself

Delete template?

Save as template?